One-year mortality in coagulase-negative Staphylococcus and Staphylococcus aureus infective endocarditis

References

• Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002; 162: 90–4
   PubMedGoogle Scholar
• Miele PS, Kogulan PK, Levy CS, Goldstein S, Marcus KA, Smith MA, et al. Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: an underappreciated disease. Am Heart J 2001; 142: 571–6
   PubMedGoogle Scholar
• Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R. Non-epidermidis coagulase-negative staphylococcal bacteraemia: clinical predictors of true bacteraemia. Eur J Clin Microbiol Infect Dis 2004; 23: 495–8
   PubMed Web of Science ®Google Scholar
• Chu VH, Cabell CH, Abrutyn E, Corey GR, Hoen B, Miro JM, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004; 39: 1527–30
   PubMed Web of Science ®Google Scholar
• Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, et al. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis 2006; 25: 365–8
   PubMedGoogle Scholar
• Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005; 41: 507–14
   PubMed Web of Science ®Google Scholar
• von EC, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677–85
   PubMedGoogle Scholar
• Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633–8
   PubMed Web of Science ®Google Scholar
• Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP, et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg 2007; 83: 1295–302
   PubMed Web of Science ®Google Scholar
• Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008; 46: 232–42
   PubMed Web of Science ®Google Scholar
• Etienne J, Eykyn SJ. Increase in native valve endocarditis caused by coagulase-negative staphylococci: an Anglo-French clinical and microbiological study. Br Heart J 1990; 64: 381–4
   PubMedGoogle Scholar
• Nissen H, Nielsen PF, Frederiksen M, Helleberg C, Nielsen JS. Native valve infective endocarditis in the general population: a 10-y survey of the clinical picture during the 1980s. Eur Heart J 1992; 13: 872–7
   PubMed Web of Science ®Google Scholar
• Pedersen SA, Foghsgaard J, Launbjerg J. Infectious endocarditis in the county of Frederiksborg, 1990–2000. Clinical findings and prognostic aspects. Ugeskr Laeger 2004; 166: 2441–6
   PubMedGoogle Scholar
• Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiological aspects of infective endocarditis in an urban population: a 5-y prospective study. Medicine (Baltimore) 1995; 74: 324–39
   PubMed Web of Science ®Google Scholar
• Wang A, Athan E, Pappas PA, Fowler VG, Jr, Olaison L, Pare C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297: 1354–61
   PubMed Web of Science ®Google Scholar
• Alestig K, Hogevik H, Olaison L. Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium. Scand J Infect Dis 2000; 32: 343–56
   PubMedGoogle Scholar
• Nihoyannopoulos P, Oakley CM, Exadactylos N, Ribeiro P, Westaby S, Foale RA. Duration of symptoms and the effects of a more aggressive surgical policy: 2 factors affecting prognosis of infective endocarditis. Eur Heart J 1985; 6: 380–90
   PubMed Web of Science ®Google Scholar
• Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf C, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005; 91: 571–5
   PubMed Web of Science ®Google Scholar
• Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: The Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25: 267–76
   PubMed Web of Science ®Google Scholar
• Kjerulf A, Tvede M, Aldershvile J, Hoiby N. Bacterial endocarditis at a tertiary hospital: how do we improve diagnosis and delay of treatment? A retrospective study of 140 patients. Cardiology 1998; 89: 79–86
   PubMedGoogle Scholar
• Olaison L, Hogevik H, Alestig K. Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997; 157: 885–92
   PubMedGoogle Scholar
• Verhagen DW, Hermanides J, Korevaar JC, Bossuyt PM, van den Brink RB, Speelman P, et al. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008; 168: 302–7
   PubMedGoogle Scholar
• Di SG, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001; 37: 1069–76
   PubMedGoogle Scholar
• Fowler VG, Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28: 106–14
   PubMed Web of Science ®Google Scholar
• Schulz R, Werner GS, Fuchs JB, Andreas S, Prange H, Ruschewski W, et al. Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990s. Eur Heart J 1996; 17: 281–8
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: 394–434
   PubMed Web of Science ®Google Scholar
• Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, et al. Changing profile of infective endocarditis: results of a 1-y survey in France. JAMA 2002; 288: 75–81
   PubMed Web of Science ®Google Scholar
• Burgert SJ, LaRocco MT, Wilansky S. Destructive native valve endocarditis caused by Staphylococcus lugdunensis. South Med J 1999; 92: 812–4
   PubMedGoogle Scholar
• Petti CA, Simmon KE, Miro JM, Hoen B, Marco F, Chu VH, et al. Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol 2008; 46: 1780–4
   PubMedGoogle Scholar